The move is aimed to “further simplify Siemens’ portfolio and refine its profile as a specialised technology company,” the Munich-based group said.

Siemens Healthineers is a global leader in the field of medical imaging and was slated to make up a 30% share of overall group revenue in 2024/2025.

Its shares closed up 0.88% prior to yesterday’s announcement, coming a day before its 2024/2025 financial results, at €44.82.

The parent firm plans to “deconsolidate” its stake in Siemens Healthineers, currently some 67%, by transferring 30% of the subsidiary’s shares to its own shareholders.

“In the medium term, the plan is to pare this stake back to a purely financial investment,” the statement indicated.

Siemens had already slightly reduced its stake in the business, which is listed separately on the Frankfurt stock exchange as part of the DAX index.

Healthineers equips hospital operating rooms worldwide with medical imaging devices and robotic arms.

Siemens, which also manufactures trains, turbines, and digital solutions, is seeking to refocus on technology activities.